You have 9 free searches left this month | for more free features.

Edaravone

Showing 51 - 70 of 70

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Amyotrophic Lateral Sclerosis Trial in Valencia (dietary supplement, other, drug)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Liposomed polyphenols resveratrol and curcumin
  • +4 more
  • Valencia, Spain
    José Enrique de la Rubia Ortí
Aug 3, 2022

Amyotrophic Lateral Sclerosis Trial in Worldwide (SAR443820, Placebo)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • La Jolla, California
  • +54 more
Feb 1, 2023

Amyotrophic Lateral Sclerosis Trial in Worldwide (Reldesemtiv, Placebo)

Completed
  • Amyotrophic Lateral Sclerosis
  • Phoenix, Arizona
  • +63 more
Aug 21, 2020

Amyotrophic Lateral Sclerosis (ALS) Trial (MCI-186, Placebo of MCI-186)

Completed
  • Amyotrophic Lateral Sclerosis (ALS)
  • (no location specified)
Nov 20, 2017

ALS Trial in Kansas City (Oxaloacetic Acid)

Unknown status
  • ALS
  • Oxaloacetic Acid
  • Kansas City, Kansas
    University of Kansas Medical Center
Dec 17, 2019

ALS Trial in Kansas City (Ranolazine 500 MG, Ranolazine 1000 MG)

Unknown status
  • ALS
  • Ranolazine 500 MG
  • Ranolazine 1000 MG
  • Kansas City, Kansas
    University of Kansas Medical Center
Jun 12, 2019

Amyotrophic Lateral Sclerosis (ALS) Trial (MCI-186, Placebo of MCI-186)

Completed
  • Amyotrophic Lateral Sclerosis (ALS)
  • (no location specified)
Apr 10, 2017

Amyotrophic Lateral Sclerosis (ALS) Trial in Osaka (MCI-186, Placebo, MCI-186 in open label phase)

Completed
  • Amyotrophic Lateral Sclerosis (ALS)
  • Osaka, Japan
    (unnamed)
Jun 26, 2018

Acute Ischemic Stroke Trial in Japan (Continuous infusion high-dose MCI-186, Continuous infusion low-dose MCI-186, Continuous

Terminated
  • Acute Ischemic Stroke
  • Continuous infusion high-dose MCI-186
  • +4 more
  • Aichi, Japan
  • +44 more
Sep 20, 2018

Acute Ischemic Stroke Trial in China (Compound Edaravone Injection, Edaravone Injection)

Completed
  • Acute Ischemic Stroke
  • Compound Edaravone Injection
  • Edaravone Injection
  • Beijing, Beijing, China
  • +47 more
Jan 12, 2017

Kidney Transplantation Trial (Edaravone, 0.9%%NaCl solution)

Unknown status
  • Kidney Transplantation
  • Edaravone
  • 0.9%%NaCl solution
  • (no location specified)
Dec 30, 2015

Acute Ischemic Stroke Trial in China (Compound Edaravone Injection, Edaravone Injection)

Completed
  • Acute Ischemic Stroke
  • Compound Edaravone Injection
  • Edaravone Injection
  • Beijing, Beijing, China
  • +27 more
Jul 1, 2015

Myocardial Infarction, Reperfusion Injury Trial in Kumamoto (edaravone)

Completed
  • Myocardial Infarction
  • Reperfusion Injury
  • edaravone
  • Kumamoto, Japan
    Department of Cardiovascular Medicine, Graduate School of Medica
Sep 12, 2014

Acute Ischemic Stroke (AIS) Trial in Helsinki, Rotterdam, Newcastle (MCI-186, Placebo)

Completed
  • Acute Ischemic Stroke (AIS)
  • Helsinki, Finland
  • +2 more
Apr 7, 2014

Nasopharyngeal Carcinoma, Brain Necrosis Trial in Guangzhou (Edaravone, Common fundamental management)

Completed
  • Nasopharyngeal Carcinoma
  • Brain Necrosis
  • Edaravone
  • Common fundamental management
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Dec 11, 2013

Acute Aortic Dissection Trial (Ulinastatin, Tranexamic acid, Edaravone)

Unknown status
  • Acute Aortic Dissection
  • (no location specified)
Jan 23, 2014

Cerebral Infarction Trial (Edaravone, Sodium Ozagrel)

Completed
  • Cerebral Infarction
  • Edaravone
  • Sodium Ozagrel
  • (no location specified)
Dec 9, 2012

Stroke Trial in Hangzhou (autologous hematopoiesis stem cell transplantation, Aspirin, Warfarin)

Unknown status
  • Stroke
  • autologous hematopoiesis stem cell transplantation
  • +4 more
  • Hangzhou, Zhejiang, China
    Yaguo Li
Jan 24, 2012

Neuroprotectants on Acute Ischemic Stroke

Unknown status
  • Acute Ischemic Stroke
    • Beijing, Beijing, China
      Tiantan hospital
    Mar 15, 2012

    Stroke Trial in Suita (Edaravone)

    Completed
    • Stroke
    • Edaravone
    • Suita, Osaka, Japan
      EAST Study Office c/o National Cardiovascular Center
    May 12, 2008